当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Editorial: 5-ASA in IBD patients on biologics—‘stop or continue’?
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-08-23 , DOI: 10.1111/apt.16541 Pauline Veyrard 1 , Stéphane Nancey 2 , Xavier Roblin 1
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-08-23 , DOI: 10.1111/apt.16541 Pauline Veyrard 1 , Stéphane Nancey 2 , Xavier Roblin 1
Affiliation
This article is linked to Bernstein et al papers. To view these articles, visit https://doi.org/10.1111/apt.16518 and https://doi.org/10.1111/apt.16554
中文翻译:
社论:使用生物制剂的 IBD 患者中的 5-ASA——“停止还是继续”?
本文链接到 Bernstein 等人的论文。要查看这些文章,请访问 https://doi.org/10.1111/apt.16518 和 https://doi.org/10.1111/apt.16554
更新日期:2021-08-24
中文翻译:
社论:使用生物制剂的 IBD 患者中的 5-ASA——“停止还是继续”?
本文链接到 Bernstein 等人的论文。要查看这些文章,请访问 https://doi.org/10.1111/apt.16518 和 https://doi.org/10.1111/apt.16554